The items were successfully added to the cart.
This site uses cookies. By continuing to browse the site, you are agreeing to our use of cookies. Find out more






Choose your prefered product category above

MAR 29TH, 2017

Regeneration or conversion to pancreatic-beta cells – A future therapeutic approach for diabetes?

In two recent publications, published in Cell and Cell Metabolism, scientists explore the possibility of promoting regeneration of ß-cells in pancreatic islets by two different approaches. 

MAR 29TH, 2017


Want to measure GLP-1? What is best, measuring active or total GLP-1? Listen to what Professor Jens Juul Holst has to say about it! In this clip he explains why it's so important to use an assay with high cross-rectivity to GLP-1 (9-36) amide.

OCT 10TH, 2016

Presenting - Mercodia Total GLP-1 NL-ELISA

We are proud to present the new Mercodia Total GLP-1 NL-ELISA, the first assay in  our new chemiluminescent product line “Northern Lights”. The Total GLP-1 NL-ELISA requires only 25 μL of human plasma and the dynamic range is 0.9-940 pmol/L.

Latest Tweet
Mercodia @Mercodia Mar 28th, 2017
Mercodia on the "big screen"! Enjoying great research at Levine Symposium in Orlando! @cityofhope #diabetes

DEC 15TH, 2016

Prof. Jens Juul Holst Webinar Recording Now Available

As a celebration of the launch of the Mercodia Total GLP-1 ELISA we invite you to listen to Dr Jens Juul Holst as he tells us about the role of the incretin GLP- in human physiology, as well as what is required of assays used to measure the different forms of GLP-1. Click "read more" to watch this and many other Mercodia Webinars.

White paper: Glucagon Pathophysiology and Pharmacology

Glucagon is dysregulated in all forms of diabetes and many of the most efficacious treatments (including bariatric surgery) affect this critical glucose regulator. Read more in our new white paper.


Mercodia Newsletters

Each year Mercodia sends out newsletters to our customers regarding Mercodia and news regarding research in the fields of diabetes, cardiovascular disease and obesity. If you've missed them, here's another chance to read them.

Mercodia Bioanalytical Service

Mercodia's Bioanalytical Service provides you with the experience, quality and reliability that are fundamental to a productive partnership. Our experienced team of managers, scientists, technicians and regulatory resources will support you in everything from study design to sample handling. We follow the most recent international guidelines and industry standard white papers for bioanalytical method development and validation.

Our combined expertise will ensure that your studies of PK, PD and biomarkers are performed with the highest possible measurement quality, enabling you to make informed decisions based on accurate bioanalytical data. We are highly flexible in the transfer of data in different formats, to meet individual sponsor needs. 


NEW WHITE PAPER on GLUCAGON MEASUREMENT Addressing Long-Standing Analytical Challenges



  • What technical aspects of commercial glucagon assays have prevented them from meeting scientists’ needs? 
  • Are there analytical solutions available to meet those needs?



Exploring Frontiers in Translational Research
Learn about scientific advances that lead to a better understanding of diseases and therapies. Interviews with scientists and clinicians will provide you with cutting-edge information, coming directly from the source.  Explore topics ranging from drug discovery and new FDA regulations to novel approaches to metabolic diseases (e.g., diabetes and heart disease).


At Mercodia, we pride ourselves on providing our customers with quick, accurate support. Below you will find answers to some common questions. If you do not find what you are looking for, please feel free to contact us: contacts


Our professional and experienced Customer Service and Technical Support teams are dedicated to ensuring complete customer satisfaction.